Literature DB >> 18292385

Blocking of platelets or intrinsic coagulation pathway-driven thrombosis does not prevent cerebral infarctions induced by photothrombosis.

Christoph Kleinschnitz1, Stefan Braeuninger, Mirko Pham, Madeleine Austinat, Ingo Nölte, Thomas Renné, Bernhard Nieswandt, Martin Bendszus, Guido Stoll.   

Abstract

BACKGROUND AND
PURPOSE: Models of photochemically-induced thrombosis are widely used in cerebrovascular research. Photothrombotic brain infarctions can be induced by systemic application of photosensitizing dyes followed by focal illumination of the cerebral cortex. Although the ensuing activation of platelets is well established, their contribution for thrombosis and tissue damage has not formally been proved.
METHODS: Infarction to the cerebral cortex was induced in mice by Rose Bengal and a cold light source. To assess the functional role of platelets, animals were platelet-depleted by anti-GPIbalpha antibodies or treated with GPIIb/IIIa-blocking F(ab)(2) fragments. The significance of the plasmatic coagulation cascade was determined by using blood coagulation factor XII (FXII)-deficient mice or heparin. Infarct development and infarct volumes were determined by serial MRI and conventional and electron microscopy.
RESULTS: There was no difference in development and final size of photothrombotic infarctions in mice with impaired platelet function. Moreover, deficiency of FXII, which initiates the intrinsic pathway of coagulation and is essential for thrombus formation, or blockade of FXa, the key protease during the waterfall cascade of plasmatic coagulation, by heparin likewise did not affect lesion development.
CONCLUSIONS: Our data demonstrate that platelet activation, factor XII-driven thrombus formation, and plasmatic coagulation pathways downstream of FX are not a prerequisite for ensuing tissue damage in models of photothrombotic vessel injury indicating that other pathomechanisms are involved. We suggest that this widely used model does not depend on platelet- or plasmatic coagulation-derived thrombosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292385     DOI: 10.1161/STROKEAHA.107.496448

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

Review 1.  Photothrombotic Stroke as a Model of Ischemic Stroke.

Authors:  Anatoly B Uzdensky
Journal:  Transl Stroke Res       Date:  2017-11-29       Impact factor: 6.829

2.  Ischemic penumbra as a trigger for intracranial pressure rise - A potential cause for collateral failure and infarct progression?

Authors:  Daniel J Beard; Caitlin L Logan; Damian D McLeod; Rebecca J Hood; Debbie Pepperall; Lucy A Murtha; Neil J Spratt
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-12       Impact factor: 6.200

3.  A novel atherothrombotic model of ischemic stroke induced by injection of collagen into the cerebral vasculature.

Authors:  Kathryn J Schunke; Thomas K Toung; Jian Zhang; Arvind P Pathak; Jiadi Xu; Jiangyang Zhang; Raymond C Koehler; Nauder Faraday
Journal:  J Neurosci Methods       Date:  2014-10-12       Impact factor: 2.390

Review 4.  Current advances in ischemic stroke research and therapies.

Authors:  Derek Barthels; Hiranmoy Das
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-15       Impact factor: 5.187

5.  Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia.

Authors:  Sara Jane Ward; Francesca Castelli; Zachary W Reichenbach; Ronald F Tuma
Journal:  Life Sci       Date:  2017-12-27       Impact factor: 5.037

Review 6.  Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke.

Authors:  Tao Yan; Michael Chopp; Jieli Chen
Journal:  Neurosci Bull       Date:  2015-12-02       Impact factor: 5.203

7.  Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.

Authors:  Stefan Braeuninger; Christoph Kleinschnitz
Journal:  Exp Transl Stroke Med       Date:  2009-11-25

8.  Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.

Authors:  Christoph Kleinschnitz; Henrike Grund; Kirstin Wingler; Melanie E Armitage; Emma Jones; Manish Mittal; David Barit; Tobias Schwarz; Christian Geis; Peter Kraft; Konstanze Barthel; Michael K Schuhmann; Alexander M Herrmann; Sven G Meuth; Guido Stoll; Sabine Meurer; Anja Schrewe; Lore Becker; Valérie Gailus-Durner; Helmut Fuchs; Thomas Klopstock; Martin Hrabé de Angelis; Karin Jandeleit-Dahm; Ajay M Shah; Norbert Weissmann; Harald H H W Schmidt
Journal:  PLoS Biol       Date:  2010-09-21       Impact factor: 8.029

9.  The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia.

Authors:  Zachary Wilmer Reichenbach; Hongbo Li; Sara Jane Ward; Ronald F Tuma
Journal:  Neurosci Lett       Date:  2016-07-21       Impact factor: 3.046

10.  Photothrombotic ischemia: a minimally invasive and reproducible photochemical cortical lesion model for mouse stroke studies.

Authors:  Vivien Labat-gest; Simone Tomasi
Journal:  J Vis Exp       Date:  2013-06-09       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.